Home Tags CanSinoBIO
CanSinoBIO Phase III clinical trials in Pakistan record an efficacy of 74.8% in protecting against COVID-19 symptoms and 100% protection against developing severe complications. WHO, DRAP and EPI conduct workshop on monitoring 'adverse events' following COVID-19 immunization. Sindh to purchase 20 million vaccine doses from China.
Research for CanSinoBIO vaccine has now entered the follow-up stage for which it has entered an agreement with the PITB to keep in contact with 18,000 volunteers. Punjab Chief Minister Usman Buzdar approves Rs. 50 million to purchase gene-sequencing technology. Punjab Health Minister Yasmin Rashid announces that Punjab has completed its COVAX trials.
China to gift Pakistan 500,000 vials of Sinopharm vaccine as goodwill gesture by end of January, reveals Foreign Minister Shah Mehmood Qureshi; Punjab Secondary Education Department carries out regular randomized testing in schools ahead of meeting to decide reopening primary and middle schools; Sputnik-V approaches DRAP for registration of vaccine which boasts 73 to 85 percent efficacy
CanSinoBIO vaccine candidate expected to begin registration as just 20% of volunteer pool remains, clinical trials of an Australian vaccine may begin in January of next year. For more updates on the second wave, keep scrolling.